ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 175630 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 175630; 2) Community: the network communities that were significantly associated with the response to NSC 175630; 3) Molecule: the relationships between components within communities and NSC 175630; 4) MDR: the compounds that were significantly associated with the NSC 175630.

NSC Compound Enrichment Correlation
NSC 311152 6H-Pyrido[4,3-b]carbazolium, 2-[2-(diethylamino)ethyl]-9-hydroxy-5,11-dimethyl-, acetate (salt) (9CI) 0.0467178916101838 0.070157164
NSC 319440 Null 0.0467178916101838 -0.11546601
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0467178916101838 0.4334077
NSC 362453 Butanedioic acid, mono[2-[3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-1(6H)-pyridazinyl]ethyl] ester 0.0467178916101838 0.29023236
NSC 58575 Pyrimidine, 2,4,5-trichloro-6-isopropyl- 0.0467178916101838 0.49933223
NSC 621360 Null 0.0467178916101838 0.39643601
NSC 626158 Hymenialdisine 0.0467178916101838 0.48534655
NSC 645161 Null 0.0467178916101838 0.29858666
NSC 648148 Null 0.0467178916101838 0.26466099
NSC 648265 [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin 0.0467178916101838 0.45548747
Total:58  Current:49    [First] [Prev] [Next] [Last]